Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response (Q84066281)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

D Mahalanabis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

T Ramamurthy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G B Nair

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A Ghosh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

S Shaikh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

B Sen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Thungapathra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R K Ghosh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G P Pazhani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R K Nandy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

S Jana

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

S K Bhattacharya

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

10 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

4850-4856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Identification of toxigenic Vibrio cholerae from the Argentine outbreak by PCR for ctx A1 and ctx A2-B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Live oral vaccines against cholera: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Classical ctxB in Vibrio cholerae O1, Kolkata, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Genetic characteristics of Matlab variants of Vibrio cholerae O1 that are hybrids between classical and El Tor biotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

ABO blood groups and cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Possible role of blood-group secretory substances in the aetiology of cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

The relationship between ABO blood groups and susceptibility to diarrhea due to Vibrio cholerae 0139

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Predisposition for cholera of individuals with O blood group. Possible evolutionary significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

7 January 2021

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

7 January 2021

Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

7 January 2021

ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.065

7 January 2021

10.1016/J.VACCINE.2009.05.065

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523608%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference